Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A. Vitanza, Michael C. Jensen, Jason S. Hauptman et al.|Nature Medicine|2025Cited by 154
STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.Navin Pinto, Julie R. Park, Catherine M. Albert et al.|Journal of Clinical Oncology|2022Cited by 27
STRIvE-01: Phase I study of EGFR806 CAR T-cell immunotherapy for recurrent/refractory solid tumors in children and young adults.Catherine M. Albert, Julie R. Park, Navin Pinto et al.|Journal of Clinical Oncology|2022Cited by 17
Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trialJuliane Gust, Julie R. Park, Bonnie Cole et al.|Neuro-Oncology|2025Cited by 16
ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma.Catherine M. Albert, Julie R. Park, Navin Pinto et al.|Journal of Clinical Oncology|2023Cited by 6